An Open Label, Single arm, Prospective Clinical Study to evaluate efficacy and safety of Hair Oil formulation in mild to moderate Hair loss in females. - NI

Emami Ltd0 个研究点目标入组 50 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Female subjects between the age group of 18- 45 years both inclusive.
•2.Subjects suffering from mild to moderate hair loss (40-140 Hair by Comb test and Finger Test).
•3.Subjects who are infrequent hair oil users.
•4.Subjects who are willing to give informed consent and ready to comply with the protocol.
•5.Subjects who are ready to provide regular follow ups till the completion of the study.

•1.Subjects with severe Hair fall due to any clinically significant disorder/s like anemia, thyroid disorders etc.
•2.Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation.
•3.Subjects with recent disease history like malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study.
•4.Subjects who have regularly used anti-hair fall treatment with hair oil over the last 6 months.
•5.Subjects who have previously undergone hair transplantation procedures.
•6.Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.
•7.Subjects on immunosuppressive drugs.
•8.Known cases of Hypersensitivity to hair oil contents.
•9.Subjects who have participated in any other clinical study since last 3 months.
•10.Subjects who are reported pregnant/planning a pregnancy or lactating.
•11.Menopausal Women.

发起方

Emami Ltd